HALOGENATED QUINDOLINE DIMERS FOR THE TREATMENT OF CANCER
The invention provides quindoline dimers where at least one quindoline moiety is substituted in the 2-position of the quindoline scaffold by an halogen atom. The compounds of the invention show advantageous properties as cytotoxic agents for their use as medicaments against cancer.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.01.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides quindoline dimers where at least one quindoline moiety is substituted in the 2-position of the quindoline scaffold by an halogen atom. The compounds of the invention show advantageous properties as cytotoxic agents for their use as medicaments against cancer. |
---|---|
Bibliography: | Application Number: EP20060763131 |